Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

DFN-11 Injection in Episodic Migraine With or Without Aura

ClinicalTrials.gov ID: NCT02569853

Public ClinicalTrials.gov record NCT02569853. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 7:35 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Safety and Efficacy of DFN-11 in patients with episodic migraines with or without aura.

Study identification

NCT ID
NCT02569853
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
268 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 21, 2015 (Actual)
Primary completion
May 30, 2017 (Actual)
Completion
Feb 26, 2018 (Actual)
Last update posted
Jul 26, 2018

2015 – 2018

United States locations

U.S. sites
16
U.S. states
14
U.S. cities
16
Facility City State ZIP Site status
Dr. Reddy's Investigational Site #18 Santa Monica California 80404 —
Dr. Reddy's Investigational Site #24 Jacksonville Florida 32256 —
Dr. Reddy's Investigational Site #23 Maitland Florida 32751 —
Dr. Reddy's Investigational Site #27 Boise Idaho 83716 —
Dr. Reddy's Investigational Site #20 Watertown Massachusetts 02472 —
Dr. Reddy's Investigational Site #19 Ann Arbor Michigan 48104 —
Dr. Reddy's Investigational Site #13 Springfield Missouri 65807 —
Dr. Reddy's Investigational Site #12 Albuquerque New Mexico 87102 —
Dr. Reddy's Investigational Site #10 Williamsville New York 14221 —
Dr. Reddy's Investigational Site #26 Greensboro North Carolina 27405 —
Dr. Reddy's Investigational Site #15 Cleveland Ohio 44122 —
Dr. Reddy's Investigational Site #21 Mt. Pleasant South Carolina 29464 —
Dr. Reddy's Investigational Site #25 Memphis Tennessee 38119 —
Dr. Reddy's Investigational Site #14 Dallas Texas 75231 —
Dr. Reddy's Investigational Site #16 Hurst Texas 76054 —
Dr. Reddy's Investigational Site #17 West Jordan Utah 84088 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02569853, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 26, 2018 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02569853 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →